Skip to content
Join our Newsletter

Search results for "Tyler Orton"

Order
Filter by category
Tech firms’ embrace of WFH leaves downtown Vancouver in ‘state of flux’

Tech firms’ embrace of WFH leaves downtown Vancouver in ‘state of flux’

Big tech companies expanding in suburbs instead, says Avison Young report
Read more >
Employers, employees lock horns over office efficiency

Employers, employees lock horns over office efficiency

Experts divided over whether working in the office increases labour productivity
Read more >
Mass layoffs at Amazon hit Vancouver offices

Mass layoffs at Amazon hit Vancouver offices

Media reports indicate as many as 10K workers are being let go this week
Read more >
B.C. inflation shows no signs of cooling, hits 7.8% in October

B.C. inflation shows no signs of cooling, hits 7.8% in October

West Coast inflation rate highest among all the large provinces
Read more >
Made-in-B.C. exoskeletons stepping up to meet market demand

Made-in-B.C. exoskeletons stepping up to meet market demand

Defence departments in Canada and the United States investing in B.C. robotics
Read more >
Axine cleantech firm taps new CEO following co-founder’s departure

Axine cleantech firm taps new CEO following co-founder’s departure

Vancouver firm goes south of the border for new leadership
Read more >
Vancouver crypto firms take beating on markets amid FTX fallout

Vancouver crypto firms take beating on markets amid FTX fallout

One B.C. crypto company’s shares have plunged 28 per cent over past week
Read more >
‘Flawed and rushed’: Investors rebuff Ritchie Bros.’ US$7B deal for IAA

‘Flawed and rushed’: Investors rebuff Ritchie Bros.’ US$7B deal for IAA

IAA shareholder unhappy with so-called 'sweetheart deal'
Read more >
Abbotsford hopes Sumas pump a ‘jump’ on future floods

Abbotsford hopes Sumas pump a ‘jump’ on future floods

City of Abbotsford awaits billions in funding in wake of 2021 flooding
Read more >
Zymeworks cuts Q3 losses to US$48M as B.C. biotech reincorporates in U.S.

Zymeworks cuts Q3 losses to US$48M as B.C. biotech reincorporates in U.S.

Despite quarterly improvement, Zymeworks' losses so far this year have totalled US$185 million
Read more >